Hemophilia News

This RSS feed URL is deprecated


This RSS feed URL is deprecated, please update. New URLs can be found in the footers at https://news.google.com/news

Roche Obtains FDA Approval For Hemophilia A Drug, Time To Push Shire Out - Seeking Alpha



Seeking Alpha
 
Roche Obtains FDA Approval For Hemophilia A Drug, Time To Push Shire Out 
Seeking Alpha
FDA approval of Hemlibra puts Roche in good position to potentially take the top spot in the Hemophilia A market. A Black box warning may reduce sales for Hemlibra, but won't be a major obstacle. Hemlibra was able to greatly reduce bleeds in patients ...
Roche gets $12 billion stock boost from positive cancer, hemophilia results Reuters
Genentech's HEMLIBRA (emicizumab-kxwh) Significantly Reduced Bleeds in Phase III Study in Hemophilia A Business Wire (press release)
Hemlibra Shows More Hemophilia A Efficacy After FDA Approval MD Magazine
KFGO  -Endpoints News 
all 30 news articles » 


FDA approves new treatment to prevent bleeding in certain patients with hemophilia A - FDA.gov



U.S. News & World Report
 
FDA approves new treatment to prevent bleeding in certain patients with hemophilia A 
FDA.gov
The U.S. Food and Drug Administration today approved Hemlibra (emicizumab-kxwh) to prevent or reduce the frequency of bleeding episodes in adult and pediatric patients with hemophilia A who have developed antibodies called Factor VIII (FVIII) inhibitors.
FDA OKs New Therapy for Some Hemophilia Patients U.S. News & World Report
FDA Approves Genentech Hemophilia Drug, But Adds Safety Warning Xconomy
Roche hemophilia drug wins FDA nod, with a warning Reuters
Business Wire  -National Hemophilia Foundation  -MPR 
all 72 news articles » 


FDA Approves Roche's Hemophilia A Biologic and Expands Indication for Leukemia Drug - BioPharm International



FDA Approves Roche's Hemophilia A Biologic and Expands Indication for Leukemia Drug 
BioPharm International
FDA has approved Hemlibra (emicizumab-kxwh), a biologic-based new molecular entity for treating hemophilia A, and has approved an additional indication for Gazyva (obinutuzumab), a leukemia biologic, to now treat follicular lymphoma. Both biologics are ...

and more » 


Roche's Hemlibra successful in late-stage study in hemophilia patients without inhibitors to factor VIII - Seeking Alpha



Roche's Hemlibra successful in late-stage study in hemophilia patients without inhibitors to factor VIII 
Seeking Alpha
Results from a Phase 3 clinical trial, HAVEN 3, assessing Roche unit (OTCQX:RHHBY) Genentech's Hemlibra (emicizumab) in adults and adolescents (at least 12 years old) with hemophilia A without inhibitors to factor VIII met its primary endpoint of ...

and more » 


European Medicines Agency Recommends Adynovi's Approval for Hemophilia A - Hemophilia News Today



Hemophilia News Today
 
European Medicines Agency Recommends Adynovi's Approval for Hemophilia A 
Hemophilia News Today
The European Medicines Agency has recommended marketing authorization for Shire's Adynovi (BAX-855) as a treatment for adults and adolescents with hemophilia A. Approval would mean the therapy could be used twice a week to prevent bleeding ...

 


Happening Today: Tesla, Tax Plan, Al Franken, Roy Moore ... - NBC New York



NBC New York
 
Happening Today: Tesla, Tax Plan, Al Franken, Roy Moore ... 
NBC New York
After more than a decade of making cars and SUVs ? and, more recently, solar panels ? Tesla Inc. wants to electrify a new type of vehicle ...

and more » 


Inside Your Health: New Hemophilia Drug - KSTP.com



KSTP.com
 
Inside Your Health: New Hemophilia Drug 
KSTP.com
There are about 20,000 people in the United States living with hemophilia, according to the Centers for Disease Control. While there is currently no cure, there are treatments. And this week, the U.S. Food and Drug Administration fast-tracked the ...

 


FDA OKs Roche's Hemlibra for hemophilia A - Seeking Alpha



FDA OKs Roche's Hemlibra for hemophilia A 
Seeking Alpha
The FDA approves Roche's (OTCQX:RHHBY +0.3%) Hemlibra (emicizumab-kxwh) for routine prophylaxis to prevent/reduce the frequency of bleeding episodes in adults and children with hemophilia A with factor VIII inhibitors, a subpopulation of ~1/3 of ...

 


Pfizer, hemophilia society launch disease-awareness app game for boys in Qatar - MobiHealthNews



MobiHealthNews
 
Pfizer, hemophilia society launch disease-awareness app game for boys in Qatar 
MobiHealthNews
Pfizer and the Friends of Haemophilia Society have launched an app game specifically designed to help boys aged four years and older learn about and manage their hemophilia. Released in Qatar, ?HemoHeroes? tasks players with guiding their 'hero' ...

 


Spark, Pfizer amend agreement for experimental hemophilia gene therapy - Philadelphia Business Journal



Philadelphia Business Journal
 
Spark, Pfizer amend agreement for experimental hemophilia gene therapy 
Philadelphia Business Journal
Spark Therapeutics and Pfizer Inc. have amended their license agreement for an experimental gene therapy for hemophilia B ? which could result in additional payments of up to $25 million for Spark. Under the amended agreement, Spark Therapeutics, ...
Spark Therapeutics and Pfizer Amend License Agreement for Investigational SPK-9001 in Hemophilia B GlobeNewswire (press release)
7 Breakout Stocks for 2018 Zacks.com

all 63 news articles »